Steve Jacob

Biotech investor | Spotting catalysts early | High conviction plays | Building toward $1M

[Steve Jacob @SteveJacob911]

Today should be a good day. Come on green day!
$sls

[Steve Jacob @SteveJacob911]

4:00 or 4:15 today?? What is everyone thinking?
$sls

[Steve Jacob @SteveJacob911]

Round 3 😁
$sls

[Steve Jacob @SteveJacob911]

Here comes the second round
$sls

[Steve Jacob @SteveJacob911]

$SLS
The loudest part of a biotech story is usually the announcement.
The quietest part is often right before it.
Right now all anyone sees is:
📉 Red candles 😴 Waiting 🤬 Frustration
What they don't see is what may be happening behind the scenes:
📊 Data review 🧬 Trial preparation 📞 Conference planning 📰 Press release drafting
Sometimes the calm before the storm feels exactly like boredom.
#SLS

[Steve Jacob @SteveJacob911]

Pretend I'm standing in front of the Sharks pitching $SLS.
"Sharks, I'm asking for a $7.15 valuation.
For that price, you get:
✅ A Phase 3 cancer immunotherapy trial ✅ 126 AML patients enrolled ✅ 78 events already reported ✅ Final analysis trigger approaching ✅ WT1 platform potential across multiple cancers
And the market currently values all of that at less than the price of two Chipotle burritos per share."
Who's in? 🦈
#SLS #Sharktank

[Steve Jacob @SteveJacob911]

$SLS

June 11 = 30 days since the 78th REGAL event update.

A lot of investors expected the 80th event by now.

Instead, we're still waiting.

The longer this goes, the more one question keeps getting louder:

Why?

#SLS #Biotech